Rapid Dose, Eco work on harm reduction pilot project

Mr. Mark Upsdell reports RAPID DOSE THERAPEUTICS AND ECO CANADIAN ORGANIC INC. INITIATE HEALTH CANADA FUNDED SUAP HARM REDUCTION PILOT PROJECT ON FIRST NATIONS USING QUICKSTRIP TO COMBAT OPIATE ADDICTION CRISIS Rapid Dose Therapeutics Corp. has launched a new significant harm reduction initiative aimed at addressing the devastating opioid crisis gripping Canada's first nations communities. In collaboration with Eco Canadian Organic Inc., a leading expert in opioid replacement therapy, Rapid Dose has initiated the substance use and addictions program harm reduction pilot project, funded by Health Canada. The initiative introduces Replace+, an Eco branded sublingual cannabis strip developed using the innovative RDT QuickStrip technology, as a potential harm reduction tool. Designed for fast-acting, convenient and precise delivery, this innovative format supports individuals in transitioning away from opioid dependence. The two-year pilot project marks a crucial step toward finding solutions to address the impact of the opiate pandemic that is affecting so many within first nations communities. Indigenous communities across Canada continue to experience a disproportionate impact from the opioid crisis, with elevated rates of overdose and addiction. This public health emergency calls for immediate and effective interventions. Through this pilot project, Replace+ aims to provide an alternative delivery method that can support individuals manage opioid withdrawal symptoms and reduce dependency, contributing to broader harm reduction strategies. Replace+ is committed to advancing the clinical application of cannabinoids across medical practices in Canada through education, mentorship, research and innovation. Regarded as a leading program in the medical cannabis community, this work emphasizes solution-focused approaches as aims to pioneer both harm-reductive and pharma-reductive applications of cannabinoid. Rapid Dose and Eco Canadian have been working closely with first nations leadership to identify culturally appropriate solutions to this growing health crisis. The collaboration represents a vital step in Rapid Dose's commitment to providing innovative and effective health care products tailored to the needs of vulnerable populations. "We are incredibly honoured to be part of this project, which represents a critical step in addressing the opioid crisis in Canada's indigenous communities," said Mark Upsdell, chief executive officer of Rapid Dose Therapeutics. "Our QuickStrip technology has the potential to offer a much needed alternative in the ongoing fight to reduce opioid-related harm, and we look forward to working alongside Eco Canadian Organic Inc. in delivering real change for those most affected by this epidemic." Denise Hannay, chief executive officer of Eco Canadian and a key driver of the project, added: "The opioid crisis has had a devastating impact on our first nations people, and it is imperative that we explore every possible option to support those who are suffering. The QuickStrip technology, through the Replace+ brand, offers a promising new avenue for harm reduction, providing a safe and effective way for individuals to begin the process of transitioning away from opioids." As this SUAP harm reduction pilot project progresses, Rapid Dose and Eco, will continue to work in close collaboration to empower individuals about their health and well-being, offering hope to those struggling with addiction, with a goal to expand the program to other first nations. Rapid Dose Therapeutics will continue to update investors and the public, and remains committed to advancing health innovation in response to Canada's most pressing public health challenges. About Rapid Dose Therapeutics Corp. Rapid Dose is a publicly traded Canadian life science company focused on the development and commercialization of innovative drug delivery technologies. Rapid Dose's flagship product, QuickStrip, is a proprietary sublingual delivery system that offers consumers a fast, convenient and precise way to administer active ingredients such as cannabis, nutraceuticals and pharmaceuticals. We seek Safe Harbor.